首页|期刊导航|外科理论与实践|结直肠癌化疗:基石地位巩固与精准化发展

结直肠癌化疗:基石地位巩固与精准化发展OA

Chemotherapy for colorectal cancer:consolidation of the cornerstone and advances in precision

中文摘要英文摘要

作为结直肠癌系统性治疗的基石,化疗(细胞毒性药物治疗)在临床实践中的应用持续精进,范围扩大.在晚期疾病治疗中,化疗与靶向、免疫药物的联合方案不断优化,形成针对不同分子亚型的精准治疗策略,显著提升疗效.在围术期治疗领域,新辅助化疗、全程新辅助治疗(TNT)的应用,以及辅助化疗的精准升级,正在重塑可切除结直肠癌病人的治疗格局.此外,循环肿瘤DNA(ctDNA)等新技术为临床决策及化疗疗效的预测与动态监测提供了可能.本文以化疗为视角,系统解析其参与结直肠癌治疗体系的作用,并探讨其临床挑战与未来方向.

As the cornerstone of systemic treatment for colorectal cancer,chemotherapy(cytotoxic drug therapy)continues to evolve in clinical practice,with its scope and application significantly expanding.In the treatment of advanced disease,the combination of chemotherapy with targeted and immunotherapeutic agents has been continuously optimized,leading to the development of precision treatment strategies tailored to different molecular subtypes,which has markedly improved therapeutic efficacy.In the field of perioperative therapy,the application of neoadjuvant chemotherapy,total neoadjuvant therapy(TNT),and the precision enhancement of adjuvant chemotherapy are reshaping the treatment landscape for patients with resectable colorectal cancer.Furthermore,novel technologies such as circulating tumor DNA offer the potential for prediction and dynamic monitoring of clinical decision and chemotherapy efficacy.From the perspective of chemotherapy,this article systematically analyzed its role in the treatment system for colorectal cancer,and discussed its clinical challenges and future directions.

姚望;张俊

上海交通大学医学院附属瑞金医院肿瘤科,上海市胃肿瘤重点实验室,上海 200025上海交通大学医学院附属瑞金医院肿瘤科,上海市胃肿瘤重点实验室,上海 200025

医药卫生

结直肠癌化疗新辅助治疗辅助治疗姑息治疗

Colorectal cancerChemotherapyNeoadjuvant therapyAdjuvant therapyPalliative treatment

《外科理论与实践》 2026 (2)

108-113,6

国家自然科学基金(82573607,82273126)

10.16139/j.1007-9610.2026.02.03

评论